awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48340923-615207F2-7A41-4E64-9926-3AC22C380357
Q48340923-615207F2-7A41-4E64-9926-3AC22C380357
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48340923-615207F2-7A41-4E64-9926-3AC22C380357
A phase I, randomized, proof-of-clinical-mechanism study assessing the pharmacokinetics and pharmacodynamics of the oral PDE9A inhibitor BI 409306 in healthy male volunteers.
P2860
Q48340923-615207F2-7A41-4E64-9926-3AC22C380357
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48340923-615207F2-7A41-4E64-9926-3AC22C380357
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f6bed4b2a995f427a1636398dc09001387b9ccd1
P2860
First-in-human study assessing safety, tolerability and pharmacokinetics of BI 409306, a selective phosphodiesterase 9A inhibitor, in healthy males.